AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

CNBC's Angelica Peebles and AstraZeneca CEO Pascal Soriot join 'Squawk Box' to discuss the company's breast cancer drug trial ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder ...

AstraZeneca's new breast cancer pill, Camizestrant, shows promising results. The drug delayed cancer progression by over six ...

AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending it now must do the same and invest more to protect its health sovereignty ...

AstraZeneca’s Pascal Soriot is no stranger to shareholder scrutiny—especially when it comes to the longtime CEO’s pay. But the latest campaign against his re-election is nothing short of ...

CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention. The probe centers around AstraZeneca’s eight or nine ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...

Is any employee worth paying £18.7m? That’s the monster sum AstraZeneca has awarded its chief executive, Pascal Soriot, who’s in line for a £1.5m salary with the rest in mostly share-based ...